Authors: Paraskevi Farmaki, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, Spyridon Savvanis, Evangelos Diamantis
Categories: Article
Source: Current Cardiology Reviews
In type 2 diabetes mellitus, there is an inadequate production of insulin or the insulin produced does not meet its purpose of introducing glucose into the cells, thus depriving them of energy. This condition is called “insulin resistance” because while there is insulin, it cannot introduce glucose into the cells and thus there is an accumulation of glucose in the blood. This is also the main disorder that occurs in the early stages of type 2 diabetes.
However, individuals can regulate the glucose produced by doing more exercise, reducing their weight and avoiding high carbohydrate foods. Insulin resistance, of course, can be continued, so patients should continue and adjust properly by means of special training, physical exercise, diet, control of their body weight, and an addition of medication (antidiabetic pills) [1]. Over time, if pancreatic cells become increasingly inactive, then patients switch to insulin therapy to properly regulate glucose and insulin levels.
Type 2 diabetes appears much later in age than Type 1 diabetes and is the most common type of diabetes. It is also called as non-insulin-dependent, since it is not treated exclusively by the use of insulin, but mainly with pills [2].
Type 2 diabetes mellitus, usually shows (because there may not be any symptom) the following frequent urination, especially in the evening (nocturia) – polyuria, polydipsia, polyphagia and intense hunger, weight loss, weakness / tiredness, lack of interest and concentration, vomiting and stomach pain, blurred vision, common infections and inflammation and wounds that are slow to heal and tingling at the extremities.
The complications of diabetes mellitus are distinguished in terms of being acute and chronic.
Diabetic ketoacidosis is a dangerous complication. It is considered an urgent event and requires the immediate transfer of the patient to the hospital. The patient has signs of dehydration, Kussmaul breath (deep, prolonged and sigh breathing) and acetone aspiration. Often, these signs are accompanied by diffuse abdominal pain. The level of consciousness is not affected initially, but then there may be a gradual decline in consciousness leading to sleepiness, lethargy and ultimately coma. In more severe cases, hypotension and circulatory shock are observed. With appropriate and timely treatment, diabetic ketoacidosis is a completely reversible condition [3].
Hypoglycemia occurs when blood sugar is very low and is a major complication of diabetes treatment. It may be caused by an incorrect dose of insulin (increased dose), intense exercise, or reduced intake of food or carbohydrate. The patient has irritability and increased sweating while there may be disorders of the level of consciousness, loss of consciousness and / or coma. Immediate ingestion of glucose by mouth (sweets, sugary soft drinks, etc.) or, if the patient is unconscious, intravenous glucose administration is required. The symptoms of hypoglycemia increased sweating, blurred vision, trembling, headache or dizziness, skin paleness, irritability, tears leakage, convulsions, distraction of attention (absent-mindedness), disturbances of perception, clumsy moves, feeling tingled around the mouth and intense desire to eat.
Hyperglycemia is called the condition in which blood sugar levels are too high. Hyperglycemia should be treated as it is the primary cause of serious and life-threatening complications in diabetes. It appears when there is no or insufficient insulin in the blood or insulin that is not working properly [4]. More often a person with diabetes mellitus develops hyperglycemia if he or she misses his or her medication or misses one or more doses. Other causes that can lead to hyperglycemia include eating sweets without proper treatment regimens or a possible infection. It is dealt with redesigning the already used therapeutic regimen, with a balanced diet and exercise [1].
Diabetes mellitus type 2 is a disease that adversely affects the functioning of almost every organ of the human body in the long run. Thus, the biggest problem for diabetic patients is the long-term complications that accompany the disease. The most common of these are [2]:
Almost all morbidity in type 2 diabetes mellitus has to do with cardiovascular diseases such as [2]:
Type 2 diabetes mellitus disorders in heart function include [2]:
Type 2 diabetes mellitus has been characterized as equivalent to coronary artery disease, while many patients with confirmed coronary artery disease suffer from diabetes mellitus or its precursor forms. 20-30% of patients with acute coronary syndromes have type 2 diabetes mellitus, while 40% of them have impaired glucose tolerance [5]. There is evidence that rates of mortality after acute myocardial infarction are twice as high for patients with diabetes as compared to patients without diabetes [5].
Therefore, cardiovascular mortality is increased by 2 to 8 times in patients with type 2 diabetes mellitus, while 75% of deaths in these patients are attributable to the underlying coronary artery disease [6]. There is evidence to suggest that in addition to coronary artery disease, type 2 diabetes mellitus is an important risk factor for arrhythmias.
The risk for cardiovascular autonomic neuropathy depends on the duration of diabetes and the degree of glycemic control and tends to co-exist along with the development of complications of other target organs such as retinopathy, nephropathy and angiopathy [7]. It is estimated that 20% of asymptomatic patients with FD have approximately cardiovascular autonomic neuropathy
Cardiovascular autonomic neuropathy may also reduce the subjective perception of myocardial ischemia. Thus, patients with diabetes have less ischemic symptoms, such as angina compared to patients without diabetes [8].
In addition, tachycardia at rest, an early manifestation of the parasympathetic system disorder in cardiovascular autonomic neuropathy, increases myocardial oxygen needs and may bring the diabetic patient closer to the ischemic threshold [6]. Additionally, cardiovascular autonomic neuropathy may cause coronary disorder vasomotor regulation, thereby disrupting the balance between myocardial delivery and demand [6].
There is evidence to suggest that QT interval prolongation in patients with diabetes is correlated with the degree of autonomic neuropathy and is an important predisposing factor for ventricular arrhythmogenesis and sudden cardiac death [7, 8].
Experimental data suggest that disturbance of the sympathetic system's function in diabetes increases the incidence of atrial fibrillation [9]. Furthermore, studies have shown that delayed intravaginal treatment and vaginal fibrosis development are important predisposing factors for atrial tachyarrhythmia diabetic experimental models [9]. In addition to experimental data, large studies have shown an important correlation between diabetes and the incidence of atrial fibrillation.
In Framingham Heart Study, diabetes mellitus was an important prognostic factor for a new odds ratio (OR) for women being 1.6 and 1.4 for men, respectively [10]. In Manitoba Follow-up Study, the prognostic factors for atrial fibrillation were determined in 3983 patients and diabetes mellitus was significantly correlated with atrial fibrillation (relative risk, RR = 1.82) in the mono-factorial analysis [11]. However, in the multi-factorial analysis, this correlation was not statistically significant, arguing that diabetes is not independent prognostic factor for atrial fibrillation. Diabetes mellitus probably promotes the incidence of atrial fibrillation through other risk factors that co-exist in these patients, such
Similarly, the results of a sub-study of the Framingham Heart Study identified independent risk factors for the incidence of atrial fibrillation in 4764 subjects in 10 years of follow-up [12]. It was observed that the association between diabetes mellitus and the incidence of atrial fibrillation did not show a statistically significant ratio (HR) = 1.10, 95% confidence interval (CI) 0.57-1.38, p = 0.43 [12].